Quantcast

Latest Histone deacetylase inhibitor Stories

2015-03-19 08:27:41

Second cohort underway in non-Hodgkin's lymphoma patients SAN DIEGO, March 19, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) has completed the first cohort in a Phase 1

2015-02-23 16:31:07

- Farydak, an HDAC inhibitor with epigenetic activity, approved in combination for patients who received at least two prior regimens including bortezomib and IMiD1 EAST HANOVER, N.J., Feb.

2015-01-12 08:29:17

HUYA holds exclusive rights to chidamide as HBI-8000 ex-China SAN DIEGO, Jan.

2015-01-06 08:31:37

Study to focus on mutations and deletions of CREBBP and EP300 genes in lymphomas SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc.

2014-12-02 08:32:46

Interim Data from 33 Evaluable Patients to be Presented at ASH on Saturday SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc.

2014-08-11 08:28:56

SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the U.S.

2014-07-30 08:33:06

Studies Support Ongoing Clinical Strategy of Using Syndax's Entinostat as Epigenetic Priming to Immune Therapy WALTHAM, Mass., July 30, 2014 /PRNewswire/ -- Syndax Pharmaceuticals,

2014-07-23 23:22:00

Transparency Market Research has added a new report titled "Histone Deacetylase Inhibitors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to


Word of the Day
quotha
  • Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.
The word 'quotha' is an alteration of 'quoth he'.
Related